Cutaneous lymphomas, also known as lymphomas of the skin, are cancers of the lymphocyte (a type of white blood cell) that are primarily in the skin, but may involve the lymph nodes, blood, and other organs. All cutaneous lymphomas are non-Hodgkin’s lymphoma (NHL).
Seattle Cancer Care Alliance (SCCA) is one of few centers in the United States that has experience treating cutaneous lymphoma and specializes in providing novel therapies and clinical studies for this rare disease.
The T-Cell Lymphoma Program began in January 2009, and SCCA is an active member of the T-Cell Consortium—a small group of T cell lymphoma specialists from around the world who are working together toward a cure for this rare disease. SCCA's Cutaneous Lymphoma Specialty Clinic brings the activities of the T-Cell Lymphoma Program directly to patients. A team of specialists from dermatology, pathology, medical oncology, and radiation oncology provide a comprehensive approach to diagnose and treat patients with cutaneous lymphoma.